Detalles de la búsqueda
1.
Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase II Study.
Front Oncol
; 12: 863655, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35433469
2.
Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer: Results From the PROSINT Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 7(5): 700-708, 2021 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33704378
3.
Target motion mitigation promotes high-precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: Results from a phase II study.
Radiother Oncol
; 146: 21-28, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32087469
Resultados
1 -
3
de 3
1
Próxima >
>>